Cresco Labs Inc. Financing Receivable, Credit Loss, Expense (Reversal)
Cresco Labs Inc. (CRLBF) reported Financing Receivable, Credit Loss, Expense (Reversal) of $170.00 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLossesExpensed · last filed 2026-03-06
| Period end | Financing Receivable, Credit Loss, Expense (Reversal) 12 month |
|---|---|
| 2025-12-31 | $170.00K 40-F · filed 2026-03-06 |
| 2024-12-31 | $330.00K 40-F · filed 2026-03-06 |
| 2023-12-31 | $314.00K 40-F · filed 2025-03-14 |